According to a November 2025 contract proposal, ICE sought vendors to help find 1.5 million people without lawful status in ...

Most Medicare beneficiaries reported manageable treatment burdens from health care. Among Medicare beneficiaries with heavier chronic condition burdens, 1 in 4 Medicare Advantage enrollees faced high ...

There were no roll call votes in the House or Senate last week. This week, Beacon Hill Roll Call reports local senators’ roll ...

Objective: To assess the correlates of changes in emergency department (ED) prices for self-pay patients from 2021 to 2023. Study Design: Retrospective longitudinal analysis of self-pay prices for ED ...

(THE CONVERSATION) President Donald Trump signed an executive order on Dec. 11, 2025, that aims to supersede state-level artificial intelligence laws that the administration views as a hindrance to ...

New analyses from the ongoing open label extension (OLE) studies and findings from electroencephalogram (EEG) assessments in ...

—Long-term Phase 1/2a and open label extension (OLE) data for zorevunersen on top of standard of care anti-seizure medicines (ASMs) demonstrate durable seizure reductions, including increases in ...

Long-term Phase 1/2a and open label extension (OLE) data for zorevunersen on top of standard of care anti-seizure medicines (ASMs)demonstrate ...

AD is a progressive, relentless disease with Aß and tau as hallmarks. It is caused by a continuous underlying neurotoxic process driven by PF that begins before amyloid plaque accumulation and ...

Stoke Therapeutics, Inc. , a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine, and Biogen Inc. today announced data presentations ...